Status:
RECRUITING
Plantar Fasciitis Randomized Clinical Control Trial
Lead Sponsor:
University of Pennsylvania
Conditions:
Plantar Fascitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided inject...
Detailed Description
Clinically, proximal PF causes plantar heel pain, which may extend into the proximal portion of the plantar longitudinal arch. Typically, the pain is most notable upon initial weight bearing ambulatio...
Eligibility Criteria
Inclusion
- Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
- ≥18 years of age
- Male or non-pregnant female of any ethnicity or race
- Active, former or non smoker
- With or without peripheral vascular disease without lower extremity intermittent claudication or rest pain
- With or without diabetes mellitus without polyneuropathy
- With or without collagen vascular disease without lower extremity wound formation.
Exclusion
- Known drug or alcohol dependence
- Chronic pain syndrome or lumbosacral radiculitis
- Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
- Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
- Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel as viewed radiographically
- Pregnant females
- Known allergy to any of the components of the injection therapy
- Previously suffered a rupture or surgery of the plantar fascia within the 5 years preceding participation in the investigation
- Existing or prior osteomyelitis of the involved calcaneus
- Unable to consent to participation in clinical research or currently be involved in another clinical investigation.
Key Trial Info
Start Date :
March 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03231150
Start Date
March 28 2017
End Date
October 31 2026
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104